Eikon Therapeutics Q1 2026 Earnings WiderthanExpected Loss as PreRevenue Biotech Advances Pipeline BELFA Q1 2026 Earnings EPS Surpasses Estimates as Stock Jumps 688 Dianthus Therapeutics Q1 2026 Earnings Narrower Loss Surprises as PreRevenue Biotech Advances Pipeline RxSight Inc Q1 2026 Earnings EPS Misses Estimates Amid Operational Headwinds ExlService Holdings Inc EXLS Q1 2026 Earnings EPS Beat Driven by Strong Operational Execution RMBS Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Revenue Discrepancy